Hjem › Virale infektioner
Virale infektioner kliniske forsøg rekrutterer i USA
31 studier for Virale infektioner rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Washington, DC12 studier
- Houston, TX6 studier
- Boston, MA6 studier
- Baltimore, MD5 studier
- Hialeah, FL5 studier
- Columbus, OH4 studier
- Dallas, TX4 studier
- Atlanta, GA4 studier
- Cincinnati, OH4 studier
- St. Louis, MO3 studier
- San Francisco, CA3 studier
- Worcester, MA3 studier
- Tampa, FL3 studier
- Boise, ID3 studier
- Miami, FL3 studier
- Omaha, NE3 studier
- Los Angeles, CA3 studier
- Durham, NC3 studier
- Salt Lake City, UT3 studier
- New York City, NY3 studier
Efter delstat
- Alabama3 studier
- Californien11 studier
- Colorado3 studier
- District of Columbia5 studier
- Florida6 studier
- Georgia5 studier
- Idaho3 studier
- Illinois3 studier
- Kentucky3 studier
- Louisiana3 studier
- Maryland14 studier
- Massachusetts6 studier
- Michigan3 studier
- Missouri4 studier
- Nebraska3 studier
- New York6 studier
- North Carolina5 studier
- Ohio9 studier
- Pennsylvania5 studier
- South Carolina3 studier
- Texas9 studier
- Utah4 studier
- Virginia4 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT05624450A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07214571Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RekruttererObservationsstudie
Alder 18 til 120 · Alle køn · Opdateret 28. sep. 2026 · NCT00006518The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
RekruttererObservationsstudie
Alder 2 til 100 · Alle køn · Opdateret 28. sep. 2026 · NCT01011712A Study of COVID-19 Vaccine(s) in Children and Adults
RekruttererFase 3Frivillige med god helbredstilstand velkomne
Alder 5 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07798648A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06679140A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT07013474Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 50 · Alle køn · Opdateret 25. sep. 2026 · NCT07706686Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 24. sep. 2026 · NCT07654283A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 50 · Alle køn · Opdateret 21. sep. 2026 · NCT07565090Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 til 50 · Alle køn · Opdateret 15. sep. 2026 · NCT06863142Viral Infections in Healthy and Immunocompromised Hosts
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
6 Months – 120 Years · Alle køn · Opdateret 14. sep. 2026 · NCT01306084Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
2 Months – 115 Years · Alle køn · Opdateret 10. sep. 2026 · NCT04419870HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RekruttererFase 1
36 Months – 22 Years · Alle køn · Opdateret 4. sep. 2026 · NCT03911388Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant
RekruttererFase 2
Alle aldre · Alle køn · Opdateret 4. sep. 2026 · NCT04230356Donor-Derived Viral Specific T-cells (VSTs)
RekruttererFase 1/2
4 Weeks · Alle køn · Opdateret 4. sep. 2026 · NCT02048332Third Party Viral Specific T-cells (VSTs)
RekruttererFase 2
2 Days · Alle køn · Opdateret 4. sep. 2026 · NCT02532452A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
RekruttererFase 1/2Frivillige med god helbredstilstand velkomne
Alder 40 til 64 · Alle køn · Opdateret 18. aug. 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
RekruttererFase 4Frivillige med god helbredstilstand velkomne
Alder 18 til 64 · Alle køn · Opdateret 7. aug. 2026 · NCT07730450Genetic Studies of Chronic Active Epstein-Barr Disease
RekruttererObservationsstudie
Alder 1 til 120 · Alle køn · Opdateret 28. jul. 2026 · NCT00032513TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
RekruttererFase 1
Alle aldre · Alle køn · Opdateret 11. jun. 2026 · NCT04013802Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
RekruttererFase 1/2
1 Month – 79 Years · Alle køn · Opdateret 15. apr. 2026 · NCT04197596A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations
RekruttererFase 4Frivillige med god helbredstilstand velkomne
6 Months · Alle køn · Opdateret 27. mar. 2026 · NCT06585241Microbial Cell-free Metagenomic Sequencing for Suspected Infections in Adult Immunocompromised Outpatients
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 30. jan. 2026 · NCT07110636Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
RekruttererFase 1
3 Months – 80 Years · Alle køn · Opdateret 26. jan. 2026 · NCT04691622Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.